Diffusion Pharmaceuticals Inc. Separation Agreements
9 Contracts & Agreements
- Form of Separation Agreement, effective as of May 31, 2024, by and between the Company and J. William Tanner, Ph.D (Filed With SEC on May 20, 2024)
- Separation Agreement and General Release, dated May 15, 2023, by and between Diffusion Pharmaceuticals Inc. and William K. Hornung (Filed With SEC on May 19, 2023)
- Separation Agreement and General Release, effective as of March 8, 2023, by and between Diffusion Pharmaceuticals and Raven Jaeger (Filed With SEC on March 24, 2023)
- Separation Agreement and General Release, effective as of March 8, 2023, by and between Diffusion Pharmaceuticals and Christopher D. Galloway, M.D (Filed With SEC on March 24, 2023)
- Form of Separation Agreement and General Release by and between Diffusion Pharmaceuticals Inc. and certain executive employees (Filed With SEC on February 16, 2023)
- Separation Agreement, dated as of September 8, 2020, by and between Diffusion Pharmaceuticals Inc. and David G. Kalergis (Filed With SEC on September 9, 2020)
- Separation Agreement, dated March 12, 2020, by and between Diffusion Pharmaceuticals Inc. and John L. Gainer (Filed With SEC on March 18, 2020)
- Separation Letter, effective as of September 26, 2018, by and between Ben L. Shealy and Diffusion Pharmaceuticals Inc (Filed With SEC on September 27, 2018)
- SEPARATION AND RELEASE AGREEMENT (Filed With SEC on June 29, 2012)
